Horse Chestnut Seeds Extract, HGC, Cream or Ointment

Pharmaceutical Licensing Product
Chemical for symptomatic treatment of RA, osteoarthritis, ankylosing spondylitis

Aenova offers a broad range of pharmaceutical license products under the following license model:
• Aenova provides and updates dossiers and scientific materia...

Pharmaceutical Licensing Product
Chemical for urinary incontinence

Aenova offers a broad range of pharmaceutical license products under the following license model:
• Aenova provides and updates dossiers and scientific material  •  Licensee prepares dossier ...

Pharmaceutical Licensing Product
Chemical for oral contraception (2nd generation)

Aenova offers a broad range of pharmaceutical license products under the following license model:
• Aenova provides and updates dossiers and scientific material  •  Licensee prepar...

Pharmaceutical Licensing Product
Chemical for pain and inflammation

Aenova offers a broad range of pharmaceutical license products under the following license model:
• Aenova provides and updates dossiers and scientific material  •  Licensee prepares dossier...

Consumer Health Care Product Concept
Cholesterol control

Aenova offers broad expertise in the development of Consumer Health Care products:
• Thorough understanding of global and regional market needs  • Creation of new product concepts based on current and foreseen innovation tre...

Pharmaceutical Licensing Product
Chemical for diabetes type II

Aenova offers a broad range of pharmaceutical license products under the following license model: 
• Aenova provides and updates dossiers and scientific material    • Licensee prepares dos...

High-potent drug products for oncology or hormone therapy will play an important role in innovative drug therapy in the future. The development and production of drugs with high-potent active ingredients is highly complex and often must be implemented with acceleration. Handling of high potent solid dosage forms therefore is a key need of current pharmaceutical development and manufacturing. To ensure safe and efficient handling of high potency products, mastering a holistic production approach is essential. This drives a fast time-to-market for your new high potent product. 
 

As a leading global contract manufacturer and development service providerwith 15 production sites in Europe and the USA, we offer extensive capabilitiesfor Steriles, Semi-Solids, Solids and Packaging.

The development of new drug products for a wide range of therapeutic areas is a rapidly growing market. Therefore, a smart innovation strategy is essential for contract developers and manufacturers. Aenova is expanding its development and production portfolio, particularly in the area of bioavailability of active pharmaceutical ingredients.

Excellence beyond Manufacturing

ENHANCING NOVEL MEDICINES

Unique ProductionKnow-How MaximizesMarket Potential

Leading Capabilities for a Growth Market

Cannabinoids can provide great benefits for the treatment of cancer and central nervous system diseases. Softgel capsules are the preferred delivery form for cannabinoid products for many reasons. Learn more with the new Aenova white paper!

High potent drug products for e.g. oncology or hormone therapy will play an important role in innovative drug therapy in the future. The development and production of drugs with high potent active ingredients is highly complex and often must be implemented with acceleration. Handling of high potent solid dosage forms therefore is a key need of current pharmaceutical development and manufacturing. To ensure safe and efficient handling of high potency products, mastering a holistic production approach is essential. This drives a fast time-to-market for your new high potent product. Learn more in the latest whitepaper from Aenova.